These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 9928024)
1. Coordinated role of vasoactive intestinal peptide and nitric oxide in cardioprotection. Das DK; Kalfin R; Maulik N; Engelman RM Ann N Y Acad Sci; 1998 Dec; 865():297-308. PubMed ID: 9928024 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological preconditioning with resveratrol: role of nitric oxide. Hattori R; Otani H; Maulik N; Das DK Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H1988-95. PubMed ID: 12003802 [TBL] [Abstract][Full Text] [Related]
3. Interplay between nitric oxide and vasoactive intestinal polypeptide in inducing fluid secretion in rat jejunum. Mourad FH; Barada KA; Abdel-Malak N; Bou Rached NA; Khoury CI; Saade NE; Nassar CF J Physiol; 2003 Aug; 550(Pt 3):863-71. PubMed ID: 12794180 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide--a retrograde messenger for carbon monoxide signaling in ischemic heart. Maulik N; Engelman DT; Watanabe M; Engelman RM; Das DK Mol Cell Biochem; 1996 Apr 12-26; 157(1-2):75-86. PubMed ID: 8739231 [TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide causes nitric oxide-dependent pulmonary vasodilation in isolated rat lung. Iwabuchi S; Ono S; Tanita T; Koike K; Fujimura S Respiration; 1997; 64(1):54-8. PubMed ID: 9044476 [TBL] [Abstract][Full Text] [Related]
6. Predominant role for nitric oxide in the relaxation induced by vasoactive intestinal polypeptide in human uterine artery. Jovanović A; Jovanović S; Tulić I; Grbović L Mol Hum Reprod; 1998 Jan; 4(1):71-6. PubMed ID: 9510014 [TBL] [Abstract][Full Text] [Related]
7. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release. Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834 [TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase contributes to intermittent hypoxia against ischemia/reperfusion injury. Ding HL; Zhu HF; Dong JW; Zhu WZ; Yang WW; Yang HT; Zhou ZN Acta Pharmacol Sin; 2005 Mar; 26(3):315-22. PubMed ID: 15715927 [TBL] [Abstract][Full Text] [Related]
9. Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide. Tosaki A; Maulik N; Elliott GT; Blasig IE; Engelman RM; Das DK J Pharmacol Exp Ther; 1998 Jun; 285(3):1274-9. PubMed ID: 9618433 [TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of inducible nitric oxide in ischemia-reperfusion of rat small intestine. Chen JC; Chen HM; Shyr MH; Fan LL; Chi TY; Chi CP; Chen MF J Formos Med Assoc; 2000 Mar; 99(3):213-8. PubMed ID: 10820953 [TBL] [Abstract][Full Text] [Related]
12. Effects of VIP and NO on the motor activity of vascularly perfused rat proximal colon. Kumano K; Fujimura M; Oshima S; Yamamoto H; Hayashi N; Nakamura T; Fujimiya M Peptides; 2001 Jan; 22(1):91-8. PubMed ID: 11179602 [TBL] [Abstract][Full Text] [Related]
13. Effect of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and reperfusion in the rat isolated perfused heart. Pabla R; Curtis MJ J Mol Cell Cardiol; 1996 Oct; 28(10):2111-21. PubMed ID: 8930806 [TBL] [Abstract][Full Text] [Related]
14. Metabolic and functional protection by selective inhibition of nitric oxide synthase 2 during ischemia-reperfusion in isolated perfused hearts. Ramasamy R; Hwang YC; Liu Y; Son NH; Ma N; Parkinson J; Sciacca R; Albala A; Edwards N; Szabolcs MJ; Cannon PJ Circulation; 2004 Apr; 109(13):1668-73. PubMed ID: 15051645 [TBL] [Abstract][Full Text] [Related]
15. Cardioprotection with pioglitazone is abolished by nitric oxide synthase inhibitor in ischemic rabbit hearts--comparison of the effects of pioglitazone and metformin. Kawabata H; Ishikawa K Diabetes Metab Res Rev; 2003; 19(4):299-305. PubMed ID: 12879407 [TBL] [Abstract][Full Text] [Related]
16. Myocardial vasoactive intestinal peptide and fibrosis induced by nitric oxide synthase inhibition in the rat. Ye VZ; Hodge G; Yong JL; Duggan KA Acta Physiol Scand; 2003 Dec; 179(4):353-60. PubMed ID: 14656372 [TBL] [Abstract][Full Text] [Related]
17. Endogenous protection against reperfusion-induced ventricular fibrillation: role of neuronal versus non-neuronal sources of nitric oxide and species dependence in the rat versus rabbit isolated heart. Pabla R; Curtis MJ J Mol Cell Cardiol; 1996 Oct; 28(10):2097-110. PubMed ID: 8930805 [TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation. Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009 [TBL] [Abstract][Full Text] [Related]
19. COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat. Patel HH; Hsu AK; Gross GJ Life Sci; 2004 May; 75(2):129-40. PubMed ID: 15120566 [TBL] [Abstract][Full Text] [Related]
20. Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium. Kalfin R; Maulik N; Engelman RM; Cordis GA; Milenov K; Kasakov L; Das DK J Pharmacol Exp Ther; 1994 Feb; 268(2):952-8. PubMed ID: 8114010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]